Mundipharma International

vorige Seite Seite 1 von 2 nächste Seite

Laborstudien bestätigen die Wirksamkeit der antiseptischen BETADINE(R)-Produkte gegen COVID-19

Die Studie wurde im Infectious Disease and Therapy Journal veröffentlicht.

OTS0033
10.07.2020 09:30
 

Mountain Rescue Study Launches to Investigate Use of Penthrox® (Methoxyflurane) for Trauma-related Pain in Hostile Environments

The Mundipharma network of independent associated companies announced today that the first patient has been enrolled into a new study investigating the efficacy of Penthrox® (methoxyflurane, MEOF) in …

OTE0002
27.03.2019 16:33
 

flutiform® k-haler®, a Novel Treatment for Adolescents and Adults With Asthma, Now Available in Europe

The Mundipharma network of independent associated companies today announces that flutiform k-haler is now available in Europe for adults and adolescents (aged 12 years and older) with asthma where the use …

OTS0069
10.09.2018 11:09
 

Largest Ever flutiform® Study Confirms Effectiveness and Tolerability in Real-world Clinical Practice: Findings from AffIRM Study to be Presented at ERS 2017

New real-world data to be presented at the European Respiratory Society (ERS) annual congress in Milan, Italy, will show that the proportion of patients with well-controlled asthma more than doubled 12 …

OTE0004
11.09.2017 11:36
 
OTS0087
11.09.2017 11:25
 

Mundipharma Files New flutiform® K-Haler® Device for Adolescents and Adults with Asthma

Mundipharma announced today that they have submitted a file to the UK regulatory authority, the Medicines and Healthcare products Regulatory Agency (MHRA) seeking a licence for its new product flutiform® …

OTE0002
30.03.2016 08:03
 

Future Doctors Unprepared to Manage Pain - One of the Most Common Problems They Will Encounter in Clinical Practice, Expert Group Warns

First ever Europe-wide study reveals that even when undergraduate medical students take a compulsory course on pain, they still only receive on average 12 hours'

OTE0003
10.10.2013 11:33
 

Mundipharma Commences COPD Trial

Mundipharma Research Limited (Mundipharma) announced today a major milestone in the development programme of flutiform(R)(fluticasone propionate / formoterol fumarate) for the treatment of Chronic …

OTE0001
19.09.2013 08:03
 

New Survey Reveals Asthma Continues to Disrupt Millions of Lives Across Europe[1],[2]

Data released on World Asthma Day suggest a more personalised approach to

OTE0001
06.05.2013 01:04
 

Record Number of Bendamustine Abstracts Accepted for Presentation at the Annual Meeting of the American Society of Hematology (ASH)

43 abstracts, announcing the results of studies involving bendamustine in a number of lymphoid malignancies, including chronic lymphocytic leukemia (CLL), multiple myeloma (MM), indolent NHL and MCL, will …

OTE0002
03.12.2012 09:08
 
OTE0016
20.09.2012 16:48
 

New Research Shows Chronic Pain is not Being Adequately Measured[1]

Experts call for patients to talk to their doctor to proactively assess their pain

OTE0001
10.10.2011 01:04
 

European Pain Experts Demand Governments Give Chronic Pain Higher Priority

A group of European pain specialists today launches a White Paper highlighting the widespread inadequate management of chronic pain and calls for governments to prioritise its prevention and management[1].

OTE0001
22.09.2011 01:04
 
vorige Seite nächste Seite